Granules concludes Covid-19 vaccine drive for its workforce
Says there has been a steep decline in Covid cases at all its facilities across Hyderabad and Vizag
Hyderabad: Granules India concluded its Covid vaccination drive of administering the second dose of vaccines to its workforce free of cost at their manufacturing sites across Hyderabad and Vizag.
The on-premises vaccination drive was conducted in association with government authorised hospitals and the vaccines were administered to over 4,500 employees as per the government approved protocols.
Since the coronavirus pandemic started, Granules recorded over 625 positive cases at their facilities. Post identification, the employees were sent to self-isolation facilities for 14 days, with all expenses borne by the company. The company has also rolled out fully paid Covid leave for infected staff.
Employees were given covid kits consisting of essential first line covid medicines, multi-vitamin tablets and oximeters. Granules has also put in place a dedicated 24/7 emergency care helpline, virtual doctor consultations, Covid-care hospital rooms with oxygen support and quarantine centres across Hyderabad and Vizag.
Commenting on the initiative Uma Chigurupati, ED, Granules, said “We believe vaccination is the only way to get over this pandemic. We thank our workforce for helping us run the facilities without any disruptions during these challenging times.”
Granules continued its focus on safety at the workplace ensuring minimum workforce while maintaining uninterrupted production of drug products with revised work-schedule and shift incentives. There has been a steep decline in cases of the coronavirus at all the facilities and has recorded nil cases from the past ten days.
Granules also supported the Telangana and Andhra Pradesh governments, with medicines, ambulances and PPE kits amounting to over Rs 10 crore.
Now you can get handpicked stories from Telangana Today on Telegram everyday. Click the link to subscribe.
Click to follow Telangana Today Facebook page and Twitter .
